Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Maple Leaf Green WorldMGWFF Debt-to-EBITDA is -27.67 as of Mar. 2026. Among 682 Drug Manufacturers companies, Maple Leaf Green World ranks worse than 146627.42% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Maple Leaf Green World's Debt-to-EBITDA or its related term are showing as below:
MGWFF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -123.57 Med: -0.97 Max: -0.1
Current: -64.74
During the past 13 years, the highest Debt-to-EBITDA Ratio of Maple Leaf Green World was -0.10. The lowest was -123.57. And the median was -0.97.
MGWFF's Debt-to-EBITDA is ranked worse than 100% of 682
companies
in the Drug Manufacturers industry
Industry Median: 1.63
vs MGWFF: -64.74
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Maple Leaf Green World Debt-to-EBITDA Related Terms
Maple Leaf Green World Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Maple Leaf Green World's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MGWFF vs CBDY, GRPS, GCAN: Debt-to-EBITDA Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Maple Leaf Green World's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maple Leaf Green World Debt-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Maple Leaf Green World's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Maple Leaf Green World's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Maple Leaf Green World (MGWFF) has a Debt-to-EBITDA of -27.67 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Maple Leaf Green World. According to the industry distribution chart, Maple Leaf Green World ranks #999999 out of 682 companies in the Drug Manufacturers industry.
Is Maple Leaf Green World's Debt-to-EBITDA too high?
Maple Leaf Green World's current Debt-to-EBITDA is -27.67. Based on the distribution chart, Maple Leaf Green World ranks #999999 out of 682 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Maple Leaf Green World's Debt-to-EBITDA compare to CBDY and GRPS?
According to the Drug Manufacturers industry distribution chart, Maple Leaf Green World ranks #999999 out of 682 companies for Debt-to-EBITDA. This places Maple Leaf Green World in the lower half of its industry. The industry median Debt-to-EBITDA is 1.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Drug Manufacturers company?
The median Debt-to-EBITDA among Drug Manufacturers companies is 1.63, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Maple Leaf Green World. For the Drug Manufacturers industry, the median Debt-to-EBITDA is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maple Leaf Green World's current Debt-to-EBITDA is -27.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maple Leaf Green World stock overvalued right now?
Maple Leaf Green World (MGWFF) has a current Debt-to-EBITDA of -27.67. The current Debt-to-EBITDA is -27.67. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Maple Leaf Green World (MGWFF), the current Debt-to-EBITDA is -27.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Maple Leaf Green World Inc is a Canadian-based development company. It is actively exploring environmentally sustainable projects within the greenhouse, solar, and renewable energy sectors in North America. The company has one reportable segment, being eco-agriculture in Canada and one in United States with the majority of the revenue been derived from Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGWFF has been successfully added to your 
